Episode
For Oncology Nurses: Ovarian Cancer — Proceedings from the 2026 Annual ONS Congress
- Published
- Jul 23, 2026
- Duration seconds
- 5420
- Processing state
not_requested- Canonical source
- https://oncologytoday.captivate.fm/episode/5957-ons2026-ovarian
Actions
POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/for-oncology-nurses-ovarian-cancer-proceedings-from-the-2026-annual-ons-congress/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/for-oncology-nurses-ovarian-cancer-proceedings-from-the-2026-annual-ons-congress.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Featuring perspectives from Dr Bradley J Monk, Dr David M O’Malley, Ms Kathryn M Schlenker and Ms Jaclyn Shaver, moderated by Dr O’Malley, including the following topics: Introduction (00:00) Overview of Ovarian Cancer (OC) (2:12) Role of PARP Inhibitors in Advanced OC (4:56) Current and Potential Future Role of Mirvetuximab Soravtansine in OC (28:45) Role of Relacorilant in Advanced OC (57:08) Utility of Immune Checkpoint Inhibition in Advanced OC (1:14:12) NCPD information and select publications